Kyle Carver

CIK: 0001757072

Transaction Breakdown

Open Market Buys (P)1 (14.3%)

High conviction signal

Open Market Sales (S)1 (14.3%)

Position reduction

Option Exercises (M)1 (14.3%)

Derivative conversions

Awards (A)2 (28.6%)

Compensation grants

Other (G, F, J, C, D, …)2 (28.6%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (1)

EVMN

Evommune, Inc.

Officer

Discretionary Trading P&L

Holdings

Transaction History (7 total)

EVMN
Evommune, Inc.
Jul 8, 2026
Purchase(P)
Direct
1K shares at avg. $13.26$13K
EVMN
Evommune, Inc.
May 28, 2026
Exercise(M)
Direct
15K shares at avg. $2.99$45K
EVMN
Evommune, Inc.
May 28, 2026
Sale(S)
Direct
18.2K shares at avg. $22.84$415K
EVMN
Evommune, Inc.
Apr 16, 2026
Award(A)
Employee Stock Option (Right to Buy)
Direct
98.9K shares-
EVMN
Evommune, Inc.
Dec 9, 2025
Tax Payment(F)
Direct
13.3K shares at avg. $17.84$237K
EVMN
Evommune, Inc.
Nov 7, 2025
Conversion(C)
Direct
3.2K shares-
EVMN
Evommune, Inc.
Nov 5, 2025
Award(A)
Employee Stock Option (Right to Buy)
Direct
279.4K shares-

		Type	Shares	Price		Ownership
Jul 8, 2026	EVMN Evommune, Inc.	Purchase(P)	1,000	$13.26	$13,260	Direct
May 28, 2026	EVMN Evommune, Inc.	Exercise(M)	15,000	$2.99	$44,850	Direct
May 28, 2026	EVMN Evommune, Inc.	Sale(S)	18,175	$22.84	$415,117	Direct
Apr 16, 2026	EVMN Evommune, Inc.	Award(A) Employee Stock Option (Right to Buy)	98,946	-	-	Direct
Dec 9, 2025	EVMN Evommune, Inc.	Tax Payment(F)	13,290	$17.84	$237,094	Direct
Nov 7, 2025	EVMN Evommune, Inc.	Conversion(C)	3,175	-	-	Direct
Nov 5, 2025	EVMN Evommune, Inc.	Award(A) Employee Stock Option (Right to Buy)	279,408	-	-	Direct

1-7 of 7 transactions

About Carver Kyle

Carver Kyle (SEC CIK 0001757072) files insider reports with the SEC as Chief Financial Officer of Evommune, Inc. (EVMN).

Signal8 holds 7 ownership filings by Carver Kyle (1 Form 3, 6 Form 4), filed between Nov 5, 2025 and Jul 10, 2026. Those filings report 7 transactions, from Nov 5, 2025 to Jul 8, 2026. Signal8's Form 4 history starts in Sep 2024.

The business address on Carver Kyle's filings is in PALO ALTO, CA.

Recent filings by Carver Kyle

Jul 8, 2026: Open-market purchase of EVMN shares (Form 4, code P).
May 28, 2026: Option exercise of EVMN shares (Form 4, code M).
May 28, 2026: Open-market sale of EVMN shares (Form 4, code S).
Apr 16, 2026: Grant or award of EVMN derivative securities (Form 4, code A).
Dec 9, 2025: Tax withholding of EVMN shares (Form 4, code F).

Other insiders filing for Evommune, Inc. (EVMN)

Pena Luis C., President & CEO
KIRSCH ARTHUR S, Director
Drew Janice Suzann, Chief of Dev. Operations
Patel Jeegar Pravinkumar, Chief Scientific Officer
MCGRAW BENJAMIN F III, Director
Cohen David E, Director

How to read Form 4 transaction codes